Protagenic Total Cashflows From Investing Activities from 2010 to 2025

PTIXW Stock  USD 0  0.00  0.00%   
Protagenic Therapeutics Total Cashflows From Investing Activities yearly trend continues to be fairly stable with very little volatility. Total Cashflows From Investing Activities is likely to outpace its year average in 2025. Total Cashflows From Investing Activities is the net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period. View All Fundamentals
 
Total Cashflows From Investing Activities  
First Reported
2010-12-31
Previous Quarter
287.5 K
Current Value
301.9 K
Quarterly Volatility
871.4 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Protagenic Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Protagenic Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 24.1 K, Interest Expense of 137.6 K or Selling General Administrative of 1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.42. Protagenic financial statements analysis is a perfect complement when working with Protagenic Therapeutics Valuation or Volatility modules.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Latest Protagenic Therapeutics' Total Cashflows From Investing Activities Growth Pattern

Below is the plot of the Total Cashflows From Investing Activities of Protagenic Therapeutics over the last few years. It is the net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period. Protagenic Therapeutics' Total Cashflows From Investing Activities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Protagenic Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Total Cashflows From Investing Activities10 Years Trend
Slightly volatile
   Total Cashflows From Investing Activities   
1.0M250.287.301.-76%15%5%100%
       Timeline  

Protagenic Total Cashflows From Investing Activities Regression Statistics

Arithmetic Mean(462,890)
Geometric Mean633,012
Coefficient Of Variation(188.25)
Mean Deviation823,520
Median250,000
Standard Deviation871,406
Sample Variance759.3B
Range2.3M
R-Value0.81
Mean Square Error284.3B
R-Squared0.65
Significance0.0002
Slope147,635
Total Sum of Squares11.4T

Protagenic Total Cashflows From Investing Activities History

2025301.9 K
2024287.5 K
2019250 K
2018M

About Protagenic Therapeutics Financial Statements

Protagenic Therapeutics investors use historical fundamental indicators, such as Protagenic Therapeutics' Total Cashflows From Investing Activities, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Protagenic Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Cashflows From Investing Activities287.5 K301.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Protagenic Stock Analysis

When running Protagenic Therapeutics' price analysis, check to measure Protagenic Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagenic Therapeutics is operating at the current time. Most of Protagenic Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagenic Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagenic Therapeutics' price. Additionally, you may evaluate how the addition of Protagenic Therapeutics to your portfolios can decrease your overall portfolio volatility.